Trial Profile
A Phase II Clinical Trial of Lenalidomide Intensification in Patients with Serologic/Asymptomatic Progression of Multiple Myeloma While on Lenalidomide Maintenance
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 May 2022
Price :
$35
*
At a glance
- Drugs Lenalidomide (Primary) ; Dexamethasone
- Indications Multiple myeloma
- Focus Therapeutic Use
- 22 Mar 2021 Status changed from active, no longer recruiting to completed.
- 01 Apr 2020 Planned End Date changed from 1 Oct 2020 to 1 Oct 2021.
- 01 Apr 2020 Planned primary completion date changed from 1 Oct 2020 to 1 Oct 2021.